Skip to main content

Elicio Therapeutics, Inc. (ELTX)

Elicio Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: $12.00 - $14.00
Current IPO price range
Chart not available yet
Market Cap180.42M
Revenue (ttm)n/a
Net Income (ttm)-18.90M
Shares Out13.88M
EPS (ttm)-1.36
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About ELTX

Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. For therapies designed to engage the immune system to treat disease, it is critical to target activation at the unique location where adaptive immune responses are generated. Our proprietary Amphiphile, or AMP, platform delivers immunotherapeutics directly to the “brain center” of the immune system - the lymph nodes. We believe this site-specific delivery of disease-specific antigens, a...

IndustryPharmaceutical Preparations
IPO DatePending
CEORobert Connelly
Employees22
Stock ExchangeNASDAQ
Ticker SymbolELTX
Full Company Profile

Financial Performance

Financial Statements

News

This Week's Scheduled IPOs

With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are sch...

Other symbols:BBCOWEBR
1 month ago - Benzinga

Elicio Therapeutics IPO Registration Document (S-1)

Elicio Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC